Health
GLP-1 medications may slightly elevate hair loss risk in susceptible men
ScienceDaily reports that GLP-1 treatments may raise hair loss odds by 7% in genetically predisposed men.
The short version
- Researchers from NYU Langone Health found that GLP-1 medications like Ozempic, Wegovy, and Zepbound are linked to a 7% increased risk of male-pattern hair loss in men genetically susceptible to baldness.[ScienceDaily]
- Prior hair shedding among patients taking these medications had generally been attributed by researchers primarily to rapid weight loss.[ScienceDaily]
- Lead investigator Lynn Petukhova stated the research offers the first genetic link between GLP-1 use and androgenetic alopecia.[ScienceDaily]
Key facts
- GLP-1 drugs including Ozempic, Wegovy, and Zepbound may increase male-pattern baldness risk by 7% in genetically susceptible men.[ScienceDaily]
- The findings were published on September 3 in the Journal of Investigative Dermatology.[ScienceDaily]
- Past shedding observed in GLP-1 patients had been largely attributed to rapid weight loss.[ScienceDaily]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.
- Ozempic and Wegovy may raise hair loss risk in some menScienceDaily - Health